Position in FTRE
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,780,557
-$10,164,599 QoQ
Shares Held
295,176
-60.7% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 99.61717754831017.ToString("F0")%
Shared 0.ToString("F0")%
None 0.3828224516898393.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Mar 31, 2025CallValue
$234,050
CallShares
31,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. FTRE ranks #160 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in FTRE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,780,557 | 295,176 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $12,945,156 | 750,444 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,840,690 | 1,525,023 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,230,276 | 856,332 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,577,159 | 341,346 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $234,050 | 31,000 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $6,213,579 | 333,168 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,189,180 | 759,459 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $32,997,365 | 1,413,769 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $59,200,397 | 1,474,848 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $50,053,298 | 1,434,192 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,669,095 | 1,177,653 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||